4
Changes in Ownership
ENANTA PHARMACEUTICALS INC Filed Acc 0001062993-24-013820
Chief Medical Officer sold 11,945 shares at an average $15.97 ($190,747)
- Chief Medical Officer acquired 5,375 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Rottinghaus Scott T. Chief Medical Officer | 2024-07-11 | Sale 10b5-1 | −4,299 | $15.07 | $64,786 | 23,988 | D |
| Rottinghaus Scott T. Chief Medical Officer | 2024-07-12 | Sale 10b5-1 | −2,271 | $15.04 | $34,156 | 21,717 | D |
| Rottinghaus Scott T. Chief Medical Officer | 2024-07-15 | Option exercise 10b5-1 | +5,375 | $8.99 | $48,321 | 27,092 | D |
| Rottinghaus Scott T. Chief Medical Officer | 2024-07-15 | Sale 10b5-1 | −5,375 | $17.08 | $91,805 | 21,717 | D |
| Derivatives | |||||||
| Rottinghaus Scott T. Chief Medical Officer | 2024-07-15 | Option exercise · Stock Option (Right to Buy) 10b5-1 | −5,375 | 80,625 | D | ||
| Open-market sales · 11,945 sh · avg $15.97 · $190,747 | |||||||
Loading xslF345X05/form4.xml…